SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-011004
Filing Date
2023-04-06
Accepted
2023-04-06 16:08:40
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A mrtx-20230404.htm   iXBRL DEF 14A 1311799
6 mrtx-20230404_g1.jpg GRAPHIC 140100
7 mrtx-20230404_g2.jpg GRAPHIC 10015
8 mrtx-20230404_g3.jpg GRAPHIC 107873
9 mrtx-20230404_g4.jpg GRAPHIC 399663
10 mrtx-20230404_g5.jpg GRAPHIC 381155
11 mrtx-20230404_g6.jpg GRAPHIC 67631
12 mrtx-20230404_g7.jpg GRAPHIC 101742
13 mrtx-20230404_g8.jpg GRAPHIC 33015
14 mrtx-20230404_g9.jpg GRAPHIC 84462
  Complete submission text file 0001628280-23-011004.txt   4986464

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrtx-20230404.xsd EX-101.SCH 4077
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrtx-20230404_def.xml EX-101.DEF 6215
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrtx-20230404_lab.xml EX-101.LAB 8297
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrtx-20230404_pre.xml EX-101.PRE 4865
17 EXTRACTED XBRL INSTANCE DOCUMENT mrtx-20230404_htm.xml XML 147687
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35921 | Film No.: 23806246
SIC: 2834 Pharmaceutical Preparations